Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P50583 (asymmetrical)
 12,197 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Dimethyl carbonate (DMC) is a versatile compound that represents an attractive eco-friendly alternative to both methyl halides (or dimethyl sulfate) and phosgene for methylation and carbonylation processes, respectively. In fact, the reactivity of DMC is tunable: at T = 90 degrees C, methoxycarbonylations take place, whereas at higher reaction temperatures, methylation reactions are observed with a variety of nucleophiles. In the particular case of substrates susceptible to multiple alkylations (e.g., CH(2)-active compounds and primary amines), DMC allows unprecedented selectivity toward mono-C- and mono-N-methylation reactions. Nowadays produced by a clean process, DMC possesses properties of nontoxicity and biodegradability which makes it a true green reagent to use in syntheses that prevent pollution at the source. Moreover, DMC-mediated methylations are catalytic reactions that use safe solids (alkaline carbonates or zeolites), thereby avoiding the formation of undesirable inorganic salts as byproducts. The reactivity of other carbonates is reported as well: higher homologues of DMC (i.e., diethyl and dibenzyl carbonate), are excellent mono-C- and mono-N-alkylating agents, whereas asymmetrical methyl alkyl carbonates (ROCO(2)Me with R > or = C(3)) undergo methylation processes with a chemoselectivity up to 99%.
 ...
PMID:The chemistry of dimethyl carbonate. 1223

Myotonic dystrophy type 1 (DM1) is a complex neuromuscular disorder caused by expansion of a CTG repeat in the 3'-untranslated region (UTR) of the DMPK gene. Mutant DMPK transcripts form aberrant structures and anomalously associate with RNA-binding proteins (RBPs). As a first step toward better understanding of the involvement of abnormal DMPK mRNA folding in DM1 manifestation, we used SHAPE, DMS, CMCT, and RNase T1 structure probing in vitro for modeling of the topology of the DMPK 3'-UTR with normal and pathogenic repeat lengths of up to 197 CUG triplets. The resulting structural information was validated by disruption of base-pairing with LNA antisense oligonucleotides (AONs) and used for prediction of therapeutic AON accessibility and verification of DMPK knockdown efficacy in cells. Our model for DMPK RNA structure demonstrates that the hairpin formed by the CUG repeat has length-dependent conformational plasticity, with a structure that is guided by and embedded in an otherwise rigid architecture of flanking regions in the DMPK 3'-UTR. Evidence is provided that long CUG repeats may form not only single asymmetrical hairpins but also exist as branched structures. These newly identified structures have implications for DM1 pathogenic mechanisms, like sequestration of RBPs and repeat-associated non-AUG (RAN) translation.
 ...
PMID:Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences. 3070 May 78